165 related articles for article (PubMed ID: 31221496)
1. Clinicopathologic features and treatment in patients with early stage uterine clear cell carcinoma: A 16-year experience.
Armbruster SD; Previs R; Soliman PT; Westin SN; Fellman B; Jhingran A; Fleming ND
Gynecol Oncol; 2019 Aug; 154(2):328-332. PubMed ID: 31221496
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant therapy of uterine clear cell carcinoma: a review.
Xu Y; Hanna RK; Elshaikh MA
Arch Gynecol Obstet; 2016 Mar; 293(3):485-92. PubMed ID: 26626183
[TBL] [Abstract][Full Text] [Related]
3. An analysis of current treatment practice in uterine papillary serous and clear cell carcinoma at two high volume cancer centers.
Vogel TJ; Knickerbocker A; Shah CA; Schiff MA; Isacson C; Garcia RL; Goff BA
J Gynecol Oncol; 2015 Jan; 26(1):25-31. PubMed ID: 25376917
[TBL] [Abstract][Full Text] [Related]
4. Impact of Chemotherapy and Radiotherapy on Management of Early Stage Clear Cell and Papillary Serous Carcinoma of the Uterus.
Hong JC; Foote J; Broadwater G; Gaillard S; Havrilesky LJ; Chino JP
Int J Gynecol Cancer; 2017 May; 27(4):720-729. PubMed ID: 28375927
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and treatment outcomes for patients with surgically staged uterine clear cell carcinoma focusing on the early stage: A Taiwanese Gynecologic Oncology Group study.
Hsu KF; Chou HH; Huang CY; Fu HC; Chiang AJ; Tsai HW; Chen JR; Cheng WF; Ke YM; Chang CC; Chen TH; Lin SH; Ho CM
Gynecol Oncol; 2014 Sep; 134(3):516-22. PubMed ID: 25019570
[TBL] [Abstract][Full Text] [Related]
6. Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi-institutional review.
Thomas M; Mariani A; Wright JD; Madarek EO; Powell MA; Mutch DG; Podratz KC; Dowdy SC
Gynecol Oncol; 2008 Feb; 108(2):293-7. PubMed ID: 18096208
[TBL] [Abstract][Full Text] [Related]
7. Uterine Clear Cell Carcinoma: Does Adjuvant Chemotherapy Improve Outcomes?
Nguyen JM; Bouchard-Fortier G; Bernardini MQ; Atenafu EG; Han G; Vicus D; Ferguson SE; Gien LT
Int J Gynecol Cancer; 2017 Jan; 27(1):69-76. PubMed ID: 27668398
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and treatment outcomes in surgically-staged non-invasive uterine clear cell carcinoma: a Turkish Gynecologic Oncology Group study.
Sarı ME; Meydanlı MM; Türkmen O; Cömert GK; Turan AT; Karalök A; Şahin H; Haberal A; Kocaman E; Akbayır Ö; Erdem B; Numanoğlu C; Güngördük K; Sancı M; Gökçü M; Özgül N; Salman MC; Boyraz G; Yüce K; Güngör T; Taşkın S; Altın D; Ortaç UF; Ayık HA; Şimşek T; Arvas M; Ayhan A
J Gynecol Oncol; 2017 Jul; 28(4):e49. PubMed ID: 28541637
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Combined Radiation and Chemotherapy on Outcome in Uterine Clear Cell Carcinoma Compared with Chemotherapy Alone.
Mahdi H; Moulton L; Nutter B; Cherian S; Rose P
Clin Oncol (R Coll Radiol); 2016 Dec; 28(12):776-782. PubMed ID: 27339402
[TBL] [Abstract][Full Text] [Related]
10. Comparison of outcomes in early-stage uterine clear cell carcinoma and serous carcinoma.
Zhang M; Yang TJ; Desai NB; DeLair D; Kollmeier MA; Makker V; Leitao MM; Abu-Rustum NR; Alektiar KM
Brachytherapy; 2019; 18(1):38-43. PubMed ID: 30316723
[TBL] [Abstract][Full Text] [Related]
11. Early-stage Uterine Pure and Mixed Clear Cell Carcinoma: Outcomes and Recurrence With and Without Adjuvant Therapy.
Chang-Halpenny CN; Natarajan S; Hwang-Graziano JM
Am J Clin Oncol; 2018 Apr; 41(4):371-378. PubMed ID: 26950465
[TBL] [Abstract][Full Text] [Related]
12. The role of adjuvant therapy in stage IA serous and clear cell uterine cancer: A multi-institutional pooled analysis.
Qu XM; Velker VM; Leung E; Kwon JS; Elshaikh MA; Kong I; Logie NA; Mendez LC; van der Putten LJ; Donovan EK; Munkarah AR; Wiebe EM; Parra-Herran C; Warner A; Louie AV; D'Souza DP
Gynecol Oncol; 2018 May; 149(2):283-290. PubMed ID: 29544706
[TBL] [Abstract][Full Text] [Related]
13. Patterns of Care, Predictors, and Outcomes of Adjuvant Therapy for Early- and Advanced-Stage Uterine Clear Cell Carcinoma: A Population-Based Analysis.
Gockley AA; Rauh-Hain JA; Anders AM; Meyer LA; Clemmer J; Lu KH; Clark RM; Schorge JO; del Carmen MG
Int J Gynecol Cancer; 2016 May; 26(4):697-704. PubMed ID: 26825834
[TBL] [Abstract][Full Text] [Related]
14. Utilization and Role of Adjuvant Radiotherapy and Chemotherapy for Uterine Clear Cell Carcinoma: A National Cancer Data Base Analysis.
Xu KM; Gill BS; Balasubramani GK; Sukumvanich P; Kelley JL; Beriwal S
Int J Gynecol Cancer; 2016 Mar; 26(3):472-82. PubMed ID: 26825837
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy, Radiation, or Combination Therapy for Stage III Uterine Cancer.
Syeda S; Chen L; Hou JY; Tergas AI; Khoury-Collado F; Melamed A; St Clair CM; Ananth CV; Neugut AI; Hershman DL; Wright JD
Obstet Gynecol; 2019 Jul; 134(1):17-29. PubMed ID: 31188310
[TBL] [Abstract][Full Text] [Related]
16. Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994.
Craighead PS; Sait K; Stuart GC; Arthur K; Nation J; Duggan M; Guo D
Gynecol Oncol; 2000 May; 77(2):248-53. PubMed ID: 10785473
[TBL] [Abstract][Full Text] [Related]
17. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
Murphy KT; Rotmensch J; Yamada SD; Mundt AJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1272-6. PubMed ID: 12654437
[TBL] [Abstract][Full Text] [Related]
18. A comparison of outcome in patients with stage 1 clear cell and grade 3 endometrioid adenocarcinoma of the endometrium with and without adjuvant therapy.
Rauh-Hain JA; Costaaggini I; Olawaiye AB; Growdon WB; Horowitz NS; del Carmen MG
Eur J Gynaecol Oncol; 2010; 31(3):284-7. PubMed ID: 21077469
[TBL] [Abstract][Full Text] [Related]
19. Prognostic determinants in patients with uterine and ovarian clear cell carcinoma: a SEER analysis.
Rauh-Hain JA; Davis M; Clemmer J; Clark RM; Growdon WB; Goodman AK; Boruta DM; Schorge JO; del Carmen MG
Gynecol Oncol; 2013 Nov; 131(2):404-9. PubMed ID: 24004647
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study.
Guttmann DM; Li H; Sevak P; Grover S; Jacobson G; Feldman A; Rubin S; Chu C; Bhatia S; Elshaikh MA; Lin LL
Int J Gynecol Cancer; 2016 Jan; 26(1):141-8. PubMed ID: 26509850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
